Interleukin-12

0Citations
Citations of this article
19Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Interleukin-12 (IL-12) is a heterodimeric cytokine and is amember of the larger family of IL-12-related cytokines. The other members of the IL-12 family include IL-23, IL-27, and IL-35. While IL-12 shares numerous structural features and molecular receptors with other members of its family, IL-12 is functionally unique (Vignali and Kuchroo, Nat Immunol 13:722-728, 2012). IL-12 was first recovered from an Epstein-Barr virus-transformed B lymphoblastoid cell line in 1989 as "natural killer-stimulating factor" (Kobayashi et al., J Exp Med 170:827-845, 1989). The following year, a separate group independently discovered IL-12 as "cytotoxic lymphocytematuration factor" (Stern et al., Proc Natl Acad SciUSA87:6808, 1990). Since its discovery, a tremendous amount of research has been conducted to characterize the physiologic function of IL-12 and assess therapeutic potential of agonist and antagonistic targeting of IL-12 for the treatment of a variety of diseases.

Cite

CITATION STYLE

APA

Kaufman, H. L., & Dharmadhikari, N. (2017). Interleukin-12. In Cancer Therapeutic Targets (Vol. 1–2, pp. 345–359). Springer New York. https://doi.org/10.1007/978-1-4419-0717-2_144

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free